BioPlus Acquisition Corp Alpha and Beta Analysis
| BIOSWDelisted Stock | USD 0.14 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioPlus Acquisition Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioPlus Acquisition over a specified time horizon. Remember, high BioPlus Acquisition's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioPlus Acquisition's market risk premium analysis include:
Beta 2.64 | Alpha 1.2 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioPlus |
BioPlus Acquisition Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioPlus Acquisition market risk premium is the additional return an investor will receive from holding BioPlus Acquisition long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioPlus Acquisition. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioPlus Acquisition's performance over market.| α | 1.20 | β | 2.64 |
BioPlus Acquisition Fundamentals Vs Peers
Comparing BioPlus Acquisition's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioPlus Acquisition's direct or indirect competition across all of the common fundamentals between BioPlus Acquisition and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioPlus Acquisition or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioPlus Acquisition's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioPlus Acquisition by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioPlus Acquisition to competition |
| Fundamentals | BioPlus Acquisition | Peer Average |
| Number Of Shares Shorted | 55.25 K | 4.71 M |
| EBITDA | (1.17 M) | 3.9 B |
| Net Income | 2 M | 570.98 M |
| Cash And Equivalents | 936 | 2.7 B |
| Total Debt | 5 M | 5.32 B |
| Debt To Equity | 7.23 % | 48.70 % |
| Book Value Per Share | 0 X | 1.93 K |
BioPlus Acquisition Opportunities
BioPlus Acquisition Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Avertix Medical Plans to Go Public Via Bios Acquisition SPAC - Bloomberg | 05/03/2023 |
2 | Global Hyaluronic Acid Based Dermal Fillers Market Size and ... - EUAC | 06/29/2023 |
About BioPlus Acquisition Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioPlus or other delisted stocks. Alpha measures the amount that position in BioPlus Acquisition Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioPlus Acquisition in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioPlus Acquisition's short interest history, or implied volatility extrapolated from BioPlus Acquisition options trading.
Build Portfolio with BioPlus Acquisition
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |